Back
Regions Financial Vs. Akero Therapeutics Industry Stock Comparison
Buy
64
RF
Regions Financial
Last Price:
$24.08
Seasonality Move:
1.21%
Sell
44
AKRO
Akero Therapeutics
Last Price:
$52.06
Seasonality Move:
45.38%
Buy
64
Regions Financial (RF)
is a Buy
Is Regions Financial a Buy, Sell or Hold?
-
The current Regions Financial [RF] share price is $24.70. The Score for RF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $52.73. The Score for AKRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RF Stock Price Chart
What is Regions Financial's stock price today?
-
The Regions Financial share price today is $24.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RF is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $52.73The current trend is moderately bearish and AKRO is experiencing slight buying pressure.
RF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.1 | Buy |
Relative Strength Index (14 RSI): | 72.35 | Buy |
Chaikin Money Flow: | 2279175 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.02 - 24.38) | Buy |
Bollinger Bands (100): | (20.28 - 23.42) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 53.6 | Buy |
Chaikin Money Flow: | 120856 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.86 - 55.26) | Sell |
Bollinger Bands (100): | (40.15 - 52.05) | Buy |
RF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.68 | Buy |
20-day SMA: | 23.46 | Buy |
50-day SMA: | 22.38 | Buy |
200-day SMA: | 23.14 | Buy |
8-day EMA: | 17.68 | Buy |
20-day EMA: | 9.73 | Buy |
50-day EMA: | 4.48 | Buy |
200-day EMA: | 1.2 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.62 | Buy |
20-day SMA: | 53.45 | Sell |
50-day SMA: | 49.34 | Buy |
200-day SMA: | 39.34 | Buy |
8-day EMA: | 52.09 | Buy |
20-day EMA: | 52.29 | Buy |
50-day EMA: | 49.9 | Buy |
200-day EMA: | 41.1 | Buy |
Regions Financial Earnings Growth & RF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.18 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Regions Financial Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |